GenMont Biotech (TPE:3164) Cash Flow for Dividends: NT$0.0 Mil (TTM As of Dec. 2025)


TPE:3164 GenMont Biotech Inc TPE:3164
82 GF Score
Price NT$16.55
GF Value NT$26.24
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GenMont Biotech Cash Flow for Dividends?

GenMont Biotech TPE:3164 +0.30% 82 Cash Flow for Dividends is NT$0.0 Mil as of Dec. 2025. GuruFocus rates TPE:3164 with a GF Score™ of 82/100 and a GF Value™ of NT$26.24 (Significantly Undervalued). The stock has 5 warning signs investors should review.

GenMont Biotech's cash flow for dividends for the three months ended in Dec. 2025 was NT$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was NT$0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

GenMont Biotech's annual payment of dividends declined from Dec. 2023 (NT$-60.5 Mil) to Dec. 2024 (NT$-19.9 Mil) but then increased from Dec. 2024 (NT$-19.9 Mil) to Dec. 2025 (NT$-69.2 Mil).

GenMont Biotech Cash Flow for Dividends Related Terms

GenMont Biotech Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for GenMont Biotech's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenMont Biotech Cash Flow for Dividends Chart

GenMont Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -60.44 -95.01 -60.46 -19.90 -69.21

GenMont Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TPE:3164
82GF Score
GenMont Biotech Inc TPE:3164
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GenMont Biotech Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of NT$0.0 Mil mean?
GenMont Biotech (TPE:3164) has a Cash Flow for Dividends of NT$0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for GenMont Biotech and its competitors.
Is GenMont Biotech's Cash Flow for Dividends too high?
GenMont Biotech's current Cash Flow for Dividends is NT$0.0 Mil. Overall, GenMont Biotech has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GenMont Biotech's Cash Flow for Dividends compare to VRTX and REGN?
GenMont Biotech's Cash Flow for Dividends of NT$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for GenMont Biotech and its competitors. GenMont Biotech's current Cash Flow for Dividends is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenMont Biotech stock overvalued right now?
Based on GuruFocus' analysis, GenMont Biotech (TPE:3164) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$26.24, compared to a current price of NT$16.55 — trading 36.9% below its estimated fair value. The current Cash Flow for Dividends is NT$0.0 Mil. GenMont Biotech's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For GenMont Biotech (TPE:3164), the current Cash Flow for Dividends is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GenMont Biotech (TPE:3164) Overvalued in 2026?

Based on GuruFocus' analysis, GenMont Biotech stock appears to be undervalued. The current stock price of NT$16.55 is trading 36.9% below its estimated GF Value™ of NT$26.24. GuruFocus considers GenMont Biotech to be Significantly Undervalued.

Key valuation signals for TPE:3164:

  • Cash Flow for Dividends: NT$0.0 Mil
  • GF Value™: NT$26.24 vs. price of NT$16.55 (36.9% below fair value)
  • GF Score™: 82/100 with 5 warning signs

No single metric tells the full story. See the TPE:3164 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GenMont Biotech Business Description

Address No. 8 Nanke 7th Road, Tainan Science and Technology Park, Shanhua District, Tainan, TWN, 741014
GenMont Biotech Inc is engaged in the research, development, manufacturing, and selling of a variety of probiotic supplements. The Group mainly engages in the manufacturing and selling of functional foods, its single operating segment.
82GF Score

Get the complete analysis for TPE:3164

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$16.55
Price
NT$26.24
GF Value